[Ustimon (ST 7090) in the treatment of coronary disease].

Renal replacement therapy in an era of socioeconomic changes--report from the Polish Registry. Nephrol Dial Transplant (1997) 1.39

The influence of propranolol on functional alterations of the electrocardiogram. Cardiologia (1968) 0.93

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. J Psychopharmacol (2008) 0.86

[Usefulness of the Michigan Alcoholism Screening Test (MAST) in Poland]. Psychiatr Pol (1986) 0.84

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder. J Psychopharmacol (2009) 0.83

Controlled delivery of antimicrobial gallium ions from phosphate-based glasses. Acta Biomater (2008) 0.82

Surface characteristics and microbial adherence ability of modified polymethylmethacrylate by fluoridated glass fillers. Aust Dent J (2014) 0.82

[Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis]. Pol Arch Med Wewn (1996) 0.81

Vitreoretinal surgery in diabetic patients on hemodialysis. Eur J Ophthalmol (1998) 0.78

Antibiotic eluting clay mineral (Laponite®) for wound healing application: an in vitro study. J Mater Sci Mater Med (2014) 0.75

A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases. Drug Deliv Transl Res (2014) 0.75

[Multicenter controlled clinical evaluation of the drug, metet]. Pol Tyg Lek (1977) 0.75

[The usefulness of M-mode and two-dimensional echocardiography in the evaluation of early and late results of mitral commissurotomy]. Kardiol Pol (1986) 0.75

[Evaluation of the effectiveness of the treatment of bacterial endocarditis with penicillin or cefamandole and determining the indications for surgical treatment. Preliminary report]. Kardiol Pol (1988) 0.75

[His bundle-branch block. Clinical and electrophysiological peculiarities]. Kardiol Pol (1976) 0.75

[Effect of beta adrenergic blocking drugs on the prognostic value of ST-segment depression during exercise electrocardiogram testing]. Kardiol Pol (1992) 0.75

[Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases]. Pol Tyg Lek (1969) 0.75

[Case of ascites during treatment with repeated dialysis]. Pol Arch Med Wewn (1978) 0.75

[Coexistence of rheumatic and bacterial endocarditis (clinical and pathological observations)]. Wiad Lek (1975) 0.75

[Radioisotope and polycardiographic technics in the evaluation of hemodynamics in patients with aortic valve diseases]. Pol Tyg Lek (1972) 0.75

[Protein polyacrylamide gel electrophoresis and level of neuraminic acids in cerebrospinal fluid in schizophrenics]. Pol Tyg Lek (1974) 0.75

[Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis]. Pol Tyg Lek (1987) 0.75

[The bradycardia-tachycardia syndrome: long-term clinical observations and electrophysiological studies]. Kardiol Pol (1978) 0.75

[Use of ultrasound for evaluating structural changes of the renal parenchyma in chronic primary glomerulopathies]. Pol Tyg Lek (1990) 0.75

[Eelctrocardiographic diagnosis of myocardial infarct in patients with implanted artificial pacemakers]. Kardiol Pol (1977) 0.75

[Sorbonit in the treatment of coronary disease]. Wiad Lek (1968) 0.75

[Mechanics of tachycardia in sick sinus syndrome]. Kardiol Pol (1976) 0.75

[Anticoagulant treatment of surgical and pregnant patients with heart valve prosthesis]. Pol Tyg Lek (1979) 0.75

[Behavior of lipids in schizophrenics]. Pol Tyg Lek (1975) 0.75

[Metabolism of magnesium and lipid disturbances in chronic renal failure]. Pol Arch Med Wewn (1997) 0.75

[Evaluation of the first lead of the left-ventricular echocardiographic inner dimension in surgically treated mitral stenosis]. Kardiol Pol (1981) 0.75

[Two-dimensional echocardiographic contrast studies in the diagnosis of congenital atrial and ventricular septal defects]. Pol Tyg Lek (1986) 0.75

[Value of electrophysiological studies in Wolff-Parkinson-White syndrome]. Kardiol Pol (1978) 0.75

[Use of the low-molecular dextran for the treatment of thrombophlebitis]. Pol Przegl Chir (1969) 0.75

[Prinzmetal's angina. Comparative analysis of late results of surgical and conservative treatment in the light of personal observations]. Kardiol Pol (1979) 0.75

[Problems of the medical secret in forensic psychiatric certification - on the basis of analyses of 150 forensic psychiatric expert's opinions issued in penal cases (author's transl)]. Psychiatr Pol (1982) 0.75

[Evaluation of regional disorders of left-ventricular contraction by two-dimensional echocardiography]. Pol Tyg Lek (1984) 0.75

[Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis]. Pol Merkur Lekarski (1997) 0.75

[Use of microcomputer technic in the hemodialysis department]. Pol Tyg Lek (1989) 0.75

[Clinical experience with Sulprim]. Z Gesamte Inn Med (1977) 0.75

[Diagnostic value of type M echocardiography and two-dimensional echocardiography in qualifying patients with mitral valve stenosis for surgical treatment]. Kardiol Pol (1984) 0.75

[Wolff-Parkinson-White syndrome. I. Clinical observations and therapeutic problems]. Kardiol Pol (1980) 0.75

[Late ventricular potentials and ventricular arrhythmia in patients with stable ischemic heart disease]. Kardiol Pol (1990) 0.75

[AIDS-phobia as a symptom or psychopathologic syndrome]. Wiad Lek (1988) 0.75

[Cordipine in the treatment of patients with exacerbated coronary disease]. Wiad Lek (1989) 0.75

[Clinical study of the action of thioridazine-retard Polfa]. Psychiatr Pol (1972) 0.75

[Combined treatment with hydrazinophthalazines and beta sympatholytic agents of nephrogenic hypertension]. Pol Tyg Lek (1976) 0.75

[Case of unusual orientation abilities (inborn capacity for localization of magnetic north pole)]. Psychiatr Pol (1982) 0.75

[Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis]. Pol Arch Med Wewn (1996) 0.75

[20 episodes of acute non-inflammatory renal failure in acquired hemolytic anemia]. Pol Arch Med Wewn (1982) 0.75

[Ultrasound in parenchymatous diseases of the kidney]. Pol Tyg Lek (1989) 0.75

[In memoriam: Prof. Wlodzimierz Musial]. Kardiol Pol (1976) 0.75

[Prevention of thromboembolism in auricular fibrillation in mitral valve disease]. Pol Tyg Lek (1981) 0.75

[Arteriovenous fistulas for hemodialysis in patients with chronic renal failure]. Pol Przegl Chir (1977) 0.75

Proarrhythmic response to antiarrhythmic drug as a risk factor for sudden cardiac death in patients with ischemic heart disease. Pacing Clin Electrophysiol (1991) 0.75

[Clinical observations and electrophysiological studies in patients with bradycardia and sick sinus syndrome]. Kardiol Pol (1977) 0.75

[Unusual course of bundle-branch block]. Kardiol Pol (1979) 0.75

[Does the appearance of pro-arrhythmic response to anti-arrhythmic drugs have prognostic significance?]. Kardiol Pol (1992) 0.75

[Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis]. Pol Arch Med Wewn (1996) 0.75

[Treatment of bacterial endocarditis]. Pol Tyg Lek (1976) 0.75